These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21483280)

  • 1. Reuma.pt - the rheumatic diseases portuguese register.
    Canhão H; Faustino A; Martins F; Fonseca JE;
    Acta Reumatol Port; 2011; 36(1):45-56. PubMed ID: 21483280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reuma.pt contribution to the knowledge of immune-mediated systemic rheumatic diseases.
    Santos MJ; Canhão H; Mourão AF; Oliveira Ramos F; Ponte C; Duarte C; Barcelos A; Martins F; Melo Gomes JA
    Acta Reumatol Port; 2017; 42(3):232-239. PubMed ID: 28917219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt.
    Martins FM; da Silva JA; Santos MJ; Vieira-Sousa E; Duarte C; Santos H; Costa JA; Pimentel-Santos FM; Cunha I; Cunha Miranda L; Nóvoa T; Cruz M; Bernardes M; Araujo D; Pereira Silva JA; Silva JC; Branco JC; Gomes JA; Faustino A; Fonseca JE; Canhão H
    Rheumatology (Oxford); 2015 Feb; 54(2):286-91. PubMed ID: 25173347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reuma.pt/vasculitis - the Portuguese vasculitis registry.
    Ponte C; Khmelinskii N; Teixeira V; Luz K; Peixoto D; Rodrigues M; Luís M; Teixeira L; Sousa S; Madeira N; Aleixo JA; Pedrosa T; Serra S; Campanilho-Marques R; Castelão W; Cordeiro A; Cordeiro I; Fernandes S; Macieira C; Madureira P; Malcata A; Vieira R; Martins F; Sequeira G; Branco JC; Costa L; Patto JV; da Silva JC; Pereira da Silva JA; Afonso C; Canhão H; Santos MJ; Luqmani RA; Fonseca JE
    Orphanet J Rare Dis; 2020 May; 15(1):110. PubMed ID: 32370776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss to follow-up in registries of rheumatic patients treated with biologics: a potential information bias in assessing pharmacovigilance and efficacy outcomes.
    Valido A; Silva-Dinis J; Cruz-Machado AR; Gonçalves MJ; Romão VC; Saavedra MJ; Fonseca JE
    Acta Reumatol Port; 2019; 44(4):281-287. PubMed ID: 32281966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some principles of the development of a clinical database/national register of selected inflammatory rheumatic diseases in the Czech Republic.
    Dostal C; Pavelka K; Zvárová J; Hanzlícek P; Olejárová M
    Int J Med Inform; 2006; 75(3-4):216-23. PubMed ID: 16169767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
    Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
    Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CoReumaPt protocol: the Portuguese cohort of rheumatic diseases.
    Laires PA; Canhão H; Araújo D; Fonseca JE; Machado P; Mourão AF; Ramiro S; Romeu JC; Santos MJ; Silva I; Silva JA; Sousa E; Tavares V; Gouveia N; Branco JC
    Acta Reumatol Port; 2012; 37(1):18-24. PubMed ID: 22781511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Predictors of Poor Prognosis in Portuguese Patients with Juvenile Idiopathic Arthritis: Data from Reuma.pt.
    Mourão AF; Santos MJ; Mendonça S; Oliveira-Ramos F; Salgado M; Estanqueiro P; Melo-Gomes J; Martins F; Lopes A; Bettencourt BF; Bruges-Armas J; Costa J; Furtado C; Figueira R; Brito I; Branco J; Fonseca JE; Canhão H
    J Immunol Res; 2015; 2015():706515. PubMed ID: 26504858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription rheumatology practices among Mexican specialists.
    Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
    Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis.
    Zink A; Thiele K; Huscher D; Listing J; Sieper J; Krause A; Gromnica-Ihle E; von Hinueber U; Wassenberg S; Genth E; Schneider M;
    J Rheumatol; 2006 Jan; 33(1):86-90. PubMed ID: 16395755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DANBIO: a nationwide registry of biological therapies in Denmark.
    Hetland ML
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S205-7. PubMed ID: 16273809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological therapies in the spondyloarthritides--the current state.
    Braun J; Sieper J
    Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement.
    Hakala M; Pöllänen R; Nieminen P
    J Rheumatol; 1993 Oct; 20(10):1674-8. PubMed ID: 8295178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
    Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
    Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland.
    Immonen K; Finne P; Grönhagen-Riska C; Pettersson T; Klaukka T; Kautiainen H; Hakala M
    Amyloid; 2011 Mar; 18(1):25-8. PubMed ID: 21284495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons for discontinuation of treatment.
    Levälampi T; Korpela M; Vuolteenaho K; Moilanen E
    Scand J Rheumatol; 2008; 37(1):6-12. PubMed ID: 18189188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GISEA: an Italian biological agents registry in rheumatology.
    Lapadula G; Ferraccioli G; Ferri C; Punzi L; Trotta F;
    Reumatismo; 2011 Nov; 63(3):155-64. PubMed ID: 22257916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.